TRIPODI, Marie Francoise
 Distribuzione geografica
Continente #
NA - Nord America 6.361
EU - Europa 1.288
AS - Asia 606
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 3
AF - Africa 2
OC - Oceania 2
Totale 8.272
Nazione #
US - Stati Uniti d'America 6.346
UA - Ucraina 583
CN - Cina 409
IT - Italia 209
IE - Irlanda 167
DE - Germania 163
VN - Vietnam 129
FI - Finlandia 118
TR - Turchia 54
SE - Svezia 37
CA - Canada 14
EU - Europa 10
FR - Francia 5
IN - India 5
GB - Regno Unito 4
BR - Brasile 3
KR - Corea 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
EG - Egitto 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
MM - Myanmar 1
MX - Messico 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SG - Singapore 1
TN - Tunisia 1
Totale 8.272
Città #
Ann Arbor 1.960
Woodbridge 724
Jacksonville 706
Houston 549
Chandler 513
Princeton 446
Wilmington 437
Dublin 167
Dong Ket 129
Nanjing 124
Andover 116
Boardman 104
Ashburn 101
Pellezzano 89
Beijing 84
Izmir 54
Fairfield 44
Hebei 43
Nanchang 41
Düsseldorf 39
Mestre 30
Shenyang 27
Jiaxing 26
Changsha 25
Tianjin 20
Norwalk 16
San Diego 14
Salerno 12
Seattle 12
Falls Church 10
Ottawa 10
Los Angeles 8
Dearborn 7
Cambridge 6
Redwood City 6
Indiana 4
Pune 4
Jinan 3
Lanzhou 3
Tappahannock 3
Toronto 3
Venezia 3
Washington 3
Dormagen 2
Guangzhou 2
Lappeenranta 2
Milan 2
Ningbo 2
Nürnberg 2
Pittsburgh 2
Solna 2
Sydney 2
São Paulo 2
Abano Terme 1
Alexandria 1
Bergamo 1
Bishkek 1
Brescia 1
Buffalo 1
Campobasso 1
Dubai 1
Easton 1
Florence 1
Grevenbroich 1
Haikou 1
Hamilton 1
Helsinki 1
Islamabad 1
Kashan 1
La Manoubia 1
Los Banos 1
Marano 1
Massa 1
Mexico 1
Misterbianco 1
Mongrando 1
Montesarchio 1
New York 1
Nottingham 1
Old Bridge 1
Padova 1
Phoenix 1
Piazzola Sul Brenta 1
Porto Torres 1
Prescott 1
Reading 1
Redmond 1
Rimini 1
Rio de Janeiro 1
San Jose 1
Santa Maria A Monte 1
Southend 1
Trieste 1
Voghera 1
Weimar 1
Xian 1
Yangon 1
Yellow Springs 1
Zhengzhou 1
Totale 6.791
Nome #
Resistance to aminoglycosides and other antibiotics among clinical isolates of Enterococcus spp. 120
Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. 109
Molecular epidemiology and mechanisms of rifampicin resistance in Acinetobacter baumannii isolates from Italy. 103
Current trends in the management of cardiac implantable electronic device (CIED) infections 103
Microsomal triglyceride transfer protein (MTP) -493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients. 96
Bile acid transport through the liver modulates biliary excretion of estrogens. 96
Attemps to revert estradiol 17-B-glucuronide cholestasis in the isolated perfused rat liver by infusion of either taurocholate or dehydrocholate. 94
Ketoconazole impairs biliary excretory function in the isolated perfused rat liver. 92
Comparative activities of isepamicin, amikacin, cefepime, and ciprofloxacin alone or in combination with other antibiotics against Stenotrophomonas maltophilia. 92
The evaluation of drug hepatotoxicity should be include the study of kupffer cell function. Comparative effect of amphotericin B and ketoconazole on the rat liver. 92
Impact of early valve surgery on outcome of staphylococcus aureus prosthetic valve infective endocarditis: Analysis in the international collaboration of endocarditis-prospective cohort study 92
Studies of the treatment of intrahepatic cholestasis in the perfused rat liver: efficacy versus toxicity of either taurocholate or taurorusodeoxycholate infusions. 91
Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. 90
PHYLOGENETIC ANALYSIS OF VIRIDANS GROUP STREPTOCOCCI CAUSING ENDOCARDITIS. 90
Neurologic complications of infective endocarditis in the elderly: results of the International Collaboration on Endocarditis Prospective Cohort Study 90
Effect of different bile acids on estradiol-17-B-glucuronide clearance by the isolated perfused rat liver. 89
Effect of amphotericin B on the biliary excretory function of the rat liver. 87
Comparison of Staphylococcus lugdunensis and staphylococcus epidermidis native valve endocarditis from the International Collaboration on Endocarditis - Prospective cohort study 87
Chronic hepatitis C (CHC) does not impair the physiologic increase of erythropoietin (EPO) production in response to the ribavirin (RBV)-induced anemia 87
Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: effects of hepatitis B virus co-infection and interferon treatment. 87
Efficacy and limitations of preemptive therapy against cytomegalovirus infections in heart transplant patients. 86
Activity of aminoglycosides against phagocytosed bacteria. 86
First definite case of aortic valve endocarditis due to Moraxella phenylpyruvica. 84
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients. 83
Estradiol-17 beta-D-glucuronide (E-17G) cholestasis in perfused rat liver: fate of E-17G and choleretic responses to bile salts. 82
Effect of taurocholate or dehydrocholate in the reversal of estradiol-17-B-glucuronide cholestasis in the isolated perfused rat liver. 82
Relationship between genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients. 81
In vitro activity effects of twelve antibiotics alone and in association against twenty-seven Enterococcus faecalis strains isolated from Italian patients withinfective endocarditis: high in vitro synergistic effect of the associationceftriaxone-fosfomycin. 81
Reversal of estradiol-17-B-glucuronide (E-17G) cholestasis by bile salts 80
Tauroursodeoxycholate (TUDC), but not taurocholate (TC), can reverse chlorpromazine (CPZ)-induced cholestasis in the isolated perfused rat liver. 80
In-Hospital and 1-Year Mortality in Patients Undergoing Early Surgery for Prosthetic Valve Endocarditis. 80
Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke. 80
Therapeutic index of taurocholate or tauroursodeoxycholate in experimental drug-induced cholestasis. 79
Unusual cases of infective endocarditis. 78
Molecular epidemiology of Streptococcus bovis causing endocarditis and bacteraemia in Italian patients. 78
HEART FAILURE IN INFECTIVE ENDOCARDITIS: A REPORT FROM THE MULTICENTER, PROSPECTIVE, OBSERVATIONAL STUDY ON ENDOCARDITIS IN ITALY (SEI) 78
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage 78
Streptococcus bovis endocarditis and its association with chronic liver disease: an underestimated risk factor. 76
Severe diarrhea occurring during alpha-interferon treatment for chronic hepatitis C is associated with serologic markers of celiac disease. 76
Candida infective endocarditis: report of 15 cases from a prospective multicenterstudy. 76
Successful treatment with ampicillin and fluoroquinolones of human endocarditis due to high-level gentamicin-resistant enterococci. 75
Cooperazione tra antibiotici e macrofagi: effetto di concentrazioni subinibenti ed effetto intrafagocitico di aztreonam, cefamandolo, netilmicina e gentamicina. 75
Streptococcus bovis in the italian endocarditis study (SEI): comparison withViridans group streptococci and enterococci. 75
Bioattività intracellulare ed extracellulare di antibiotici verso E.coli. 74
Ameliorating effect of tauroursodeoxycholate (TUDC) but not taurocholate (TC) on chlorpromazine (CPZ) cholestasis. 74
Treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies. 74
Management of Gram-negative and fungal endocarditis 73
Prevention of the toxicity of erythromycin estolate in the perfused rat liver by endotoxin. 73
Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases. 73
Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae. 73
Influence of tauroursodeoxycholic and taurodeoxycholic acids on hepatic metabolism and biliary secretion of phosphatidylcholine in the isolated rat liver. 72
Effect of bile acids on hepatic metabolism and bilary secretion of 16: 0-(14C) 18:2 phosphatidylcholine. 72
Attività intracellulare di gentamicina, netilmicina e streptomicina verso E. coli fagocitati da macrofagi. 72
Genotypic diversity of coagulase-negative staphylococci causing endocarditis: a global perspective. 72
Rhodococcus equi endocarditis in immunocompetent hosts: report of the first two cases. 71
Report on 509 definite cases of infectious endocarditis of the multicentric Italian study (SEI) 71
Central venous catheter-related biofilm infections: An up-to-date focus on meticillin-resistant Staphylococcus aureus 71
Unorthodox antibiotic combinations including ciprofloxacin against high-level gentamicin resistant enterococci. 70
Attività dei macrofagi peritoneali verso E.coli trattato con concentrazioni subinibenti di cefamandolo. 69
Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C. 68
Intracellular activity of cefamandole and aztreonam against phagocytosed Escherichia coli and Staphylococcus aureus. 68
Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C. 67
Molecular epidemiology of a clonal outbreak of multidrug-resistant Acitenobacter baumanii in a university hospital in Italy. 67
Endocarditis abscess of the aortic annulus involving the left ventricular inferior wall and causing a moderate aortic systolic obstruction: diagnosis by transthoracic and transesophageal echocardiography. 67
Leptotrichia endocarditis: report of two cases from the International Collaboration on Endocarditis (ICE) database and review of previous cases. 66
Different susceptibility of coagulase-positive and coagulase-negative staphylococci to ciprofloxacin. 66
Influence of subinhibitory concentrations of loracarbef (LY 163892) and daptomycin (LY 146032) on bacterial phagocytosis, killing and serum sensitivity. 66
Hepatic cryptococcosis in a heart transplant recipient. 66
Rhodococcus equi as a cause of infective endocarditis: description of 2 clinical cases 66
Current trends in infective endocarditis in italy: report on 852 cases from the multicenter, prospective SEI study. 66
Prevalence of antibiotic resistance among clinical isolates of methicillin-resistant staphylococci. 65
Improved outcome of pulmonary aspergillosis in heart transplant recipients with early diagnosis and itraconazole treatment. 65
In vitro activity of multiple antibiotic combinations against Nocardia:relationship with a short-term treatment strategy in heart transplant recipients with pulmonary nocardiosis. 65
Toxicity of amphotericin B on sinusoidal parenchymal cells of the rat liver. 65
Effects of amphotericin B on the excretory function and the colloid clearance capacity of the perfused rat liver. 64
Kinetics of phagocytosis and killing of E. coli by murine macrophages in presence of different serum preparations. 64
Inhaled tobramycin in children with acute bacterial rhinopharyngitis. 64
Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. 64
An in vitro study of treatment of drug-induced cholestasis by tauroursodeoxycholate (TUDC) 64
Antibiotici e sistema immune dell'ospite: bioattività intrafagocitica di antibiotici. 64
Current features of infective endocarditis in persons on hemodialysis: a prevalence study with case control design from the prospective multicenter SEI cohort 64
Reversal of drug-induced cholestasis by tauroursodeoxycholate (TUDC) in the isolated perfused rat liver (IPRL): a biochemical and ultrastructural study. 63
Current features of infective endocarditis with microbiologically-negative Blood cultures. 63
Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. 62
Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy. 61
Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon. 60
The effects of the level of ampicillin resistance and the inoculum size on the in-vitro bactericidal activity of the combination of ampicillin and ciprofloxacin against high-level gentamicin-resistant strains of Enterococcus faecium. 60
Effect of taurodeoxycholic acid on the biliary secretion of individual lecithins in the isolated perfused rat liver. 59
Effects of bile salt infusion on chlorpromazine-induced cholestasis in the isolated perfused rat liver. 56
Risk factors for "major" embolic events in hospitalized patients with infective endocarditis. 56
Nocardia brasiliensis in Italy: A nine-year experience. 55
[Cholestatic effect of amphotericin B on the isolated perfused rat liver. Preliminary observations] 55
Coagulase-negative staphylococcal prosthetic valve endocarditis--a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study. 55
Interactive Medicine: Infezioni Batteriche. Le infezioni in gastroenterologia 55
Effetto di concentrazioni subinibenti ed attività intrafagocitica di antbiotici 55
Fagocitosi e killing di differenti ceppi batterici pretrattati con concentrazioni subinibenti di LY 163892 e LY 146032. 55
Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. 55
Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study 54
In-vitro activity of combined ampicillin and ciprofloxacin against high-level gentamicin-resistant strains of Enterococcus faecium: influence of the medium on susceptibility test results. 54
Sensibilità agli antibiotici di stafilococchi ed enterococchi recentemente isolati da pazienti con severe infezioni. 54
Totale 7.398
Categoria #
all - tutte 19.598
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.598


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201972 0 0 0 0 0 0 0 0 0 0 70 2
2019/20201.048 325 4 120 2 113 11 121 7 120 72 148 5
2020/2021902 8 119 119 0 119 15 121 2 126 3 129 141
2021/2022734 0 1 0 9 7 14 5 40 124 109 89 336
2022/20231.196 123 24 28 139 208 292 0 104 209 4 32 33
2023/2024315 60 99 25 15 24 35 22 21 0 14 0 0
Totale 8.388